"A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/-Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or Less."
Gordan Srkalovic MD, PhD
Patient must have a diagnosis of node positive invasive breast cancer with positive estrogen &/or progesterone receptor status and negative HER2 Undergo axillary staging by sentinel node biopsy or axillary lymph node dissection
Contact for Questions
Sparrow Cancer Center 800-968-5570